Large-scale testing (Phase 3)Not Yet RecruitingNCT06606093
What this trial is testing
Evaluate the Efficacy and Safety of DWP16001 in Type 2 Diabetic Nephropathy with Moderate Renal Impairment Patients
Who this might be right for
Type 2 Diabetic Nephropathy
Daewoong Pharmaceutical Co. LTD. 348